Home NDC 0024-5803-90 Xyzal
Product NDC 0024-5803
Requested package NDC 0024-5803-90
11-digit product format 000245803
Labeler code 0024
Product ID 0024-5803_e96c760a-8427-4e90-a3fd-5bc091016a3a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name levocetirizine dihydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Sanofi-Aventis U.S. LLC
Application NDA022064
Marketing category NDA
Marketing start 2017-07-24
Marketing end 0000-00-00
Substance LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength 5 mg/1
Pharmacologic classes Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022064-001 XYZAL LEVOCETIRIZINE DIHYDROCHLORIDE 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022064-001 XYZAL 5MG TABLET / ORAL RLD 2007-05-25 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022064-001 XYZAL 5MG TABLET / ORAL RLD 2007-05-25 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022064-001 XYZAL 5MG TABLET / ORAL RLD 2007-05-25 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022064-001 XYZAL 5MG TABLET / ORAL RLD 2007-05-25 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022064-001 XYZAL 5MG TABLET / ORAL RLD 2007-05-25 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022064-001 XYZAL 5MG TABLET / ORAL AB RLD, RS 2007-05-25 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022064-001 XYZAL 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2007-05-25 e64feba35796…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Xyzal LEVOCETIRIZINE DIHYDROCHLORIDE Chattem, Inc. 1673f7ff-0c7c-4403-86cf-c05eb1475222 2025-07-22 Warnings, Adverse reactions Exact identifier application applno (NDA): 022064 application number: NDA022064
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0024-5803-90 00024580390 90 TABLET, FILM COATED in 1 BOTTLE (0024-5803-90) 2017-07-24 0000-00-00 No No Current